CAPELLO, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 5.804
EU - Europa 5.736
AS - Asia 3.355
SA - Sud America 613
Continente sconosciuto - Info sul continente non disponibili 124
AF - Africa 90
OC - Oceania 1
Totale 15.723
Nazione #
US - Stati Uniti d'America 5.674
RU - Federazione Russa 1.443
IE - Irlanda 1.201
SG - Singapore 965
CN - Cina 890
DE - Germania 624
HK - Hong Kong 605
SE - Svezia 605
IT - Italia 592
UA - Ucraina 487
BR - Brasile 456
VN - Vietnam 436
FI - Finlandia 306
FR - Francia 209
GB - Regno Unito 104
IN - India 100
KR - Corea 85
CA - Canada 71
BD - Bangladesh 65
AR - Argentina 47
BE - Belgio 33
ID - Indonesia 33
NL - Olanda 32
MX - Messico 31
ZA - Sudafrica 31
EC - Ecuador 30
IR - Iran 28
JP - Giappone 27
PL - Polonia 26
TR - Turchia 26
CO - Colombia 22
EU - Europa 22
VE - Venezuela 20
ES - Italia 19
IQ - Iraq 19
BJ - Benin 14
PH - Filippine 13
AT - Austria 12
PK - Pakistan 12
PY - Paraguay 12
UZ - Uzbekistan 12
CL - Cile 10
LT - Lituania 10
TN - Tunisia 10
MA - Marocco 8
PE - Perù 8
EG - Egitto 7
MD - Moldavia 7
CZ - Repubblica Ceca 6
JM - Giamaica 6
KE - Kenya 6
IL - Israele 5
SA - Arabia Saudita 5
CR - Costa Rica 4
EE - Estonia 4
UY - Uruguay 4
DZ - Algeria 3
HN - Honduras 3
KZ - Kazakistan 3
PT - Portogallo 3
RO - Romania 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BO - Bolivia 2
BS - Bahamas 2
BW - Botswana 2
CH - Svizzera 2
CI - Costa d'Avorio 2
GT - Guatemala 2
GY - Guiana 2
HR - Croazia 2
LB - Libano 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
IS - Islanda 1
JO - Giordania 1
KN - Saint Kitts e Nevis 1
MN - Mongolia 1
Totale 15.619
Città #
Dublin 1.201
Jacksonville 879
Hong Kong 603
San Jose 528
Dearborn 436
Singapore 399
Ashburn 342
Council Bluffs 311
Wilmington 307
Chandler 291
Beijing 255
Moscow 181
Ho Chi Minh City 157
Lawrence 154
Princeton 154
Lauterbourg 139
San Mateo 136
Los Angeles 125
Andover 103
Ann Arbor 99
Buffalo 92
Hanoi 87
Seoul 82
New York 69
Novara 69
Boardman 60
Columbus 60
Milan 60
Piemonte 59
Santa Clara 54
Dallas 48
São Paulo 39
Houston 36
Nanjing 35
Orem 35
Turin 34
Guangzhou 33
Philadelphia 32
Frankfurt am Main 31
Rome 29
Kunming 27
Seattle 27
Toronto 25
Chennai 24
Tianjin 24
Tokyo 24
Brussels 23
Hefei 23
Chicago 22
Da Nang 20
Johannesburg 20
Woodbridge 20
Denver 19
Hangzhou 19
Montreal 19
Munich 19
Atlanta 18
Bremen 18
Redondo Beach 18
Rio de Janeiro 18
Amsterdam 17
London 17
Norwalk 17
Sacramento 17
Warsaw 17
Haiphong 16
Helsinki 16
Jinan 16
Nuremberg 16
Strasbourg 16
Brooklyn 15
Phoenix 15
Savignano Sul Panaro 15
Shanghai 15
Torino 15
Cotonou 14
Falls Church 14
Las Vegas 14
Vercelli 14
Jakarta 13
Nanchang 13
Zanjan 13
Boston 12
Guayaquil 12
Mexico City 12
Mumbai 12
Tashkent 12
Ankara 11
Brasília 11
Düsseldorf 11
Hải Dương 11
Manchester 11
Bologna 10
Fairfield 10
St Louis 10
Fuzhou 9
Grafing 9
Medellín 9
Poplar 9
Porto Alegre 9
Totale 8.796
Nome #
Structure activity relationship studies on Amb639752: toward the identification of a common pharmacophoric structure for DGKα inhibitors 245
Dissecting the Mechanism of Action of Spiperone— A Candidate for Drug Repurposing for Colorectal Cancer 242
Identification of a novel DGKa inhibitor for XLP-1 therapy by virtual screening 196
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma 179
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 178
Public Attitude towards Biobanking: An Italian University Survey 173
Psychotropic Drugs Show Anticancer Activity by Disrupting Mitochondrial and Lysosomal Function 162
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 154
Identification of Key Phospholipids That Bind and Activate Atypical PKCs 149
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 143
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 143
IL LINFOMA PRIMITIVO DELLE SIEROSE E ALTRE MALATTIE LINFOPROLIFERATIVE ASSOCIATE AD HHV-8 140
SIMIAN AIDS-RELATED LYMPHOMA GROWTH IN SCID MICE IS INDEPENDENT OF KARYOTYPIC ABNORMALITIES OR BCL-6 MUTATIONS 136
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma 136
ANALYSIS OF HUMAN HERPESVIRUS TYPE-8 INFECTION IN AIDS-RELATED AND AIDS-UNRELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA 135
The diacylglycerol kinase α/atypical PKC/β1 integrin pathway in SDF-1α mammary carcinoma invasiveness. 133
Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency-related non-Hodgkin lymphomas 132
Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands 130
LINFOMI NON-HODGKIN (NHL) E LINFOMA DI HODGKIN (HD) ASSOCIATI ALL'INFEZIONE DA HIV. CARATTERISTICHE EPIDEMIOLOGICHE, PATOLOGICHE, MOLECOLARI E CLINICHE NELL'ERA DELL'HAART 127
AIDS ASSOCIATED LYMPHOMAS ARE EFFICIENTLY LYSED THROUGH COMPLEMENT DEPENDENT CYTOTOXICITY (CDC) AND ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) BY RITUXIMAB 127
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders 126
Evaluating Cryopreservation Methods in Biobanking: Impacts on Biomarker Integrity and Omics Data Reliability 125
EXPRESSION OF MUM-1/IRF4 SELECTIVELY CLUSTERS WITH PRIMARY EFFUSION LYMPHOMA AMONG LYMPHOMATOUS EFFUSIONS. IMPLICATIONS FOR DISEASE HISTOGENESIS AND PATHOGENESIS 125
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 125
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 125
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 124
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 122
Investigating aging trajectories and determinants in Northern Italy through the Novara cohort study 121
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia 121
Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma 121
PATTERNS OF CYTOKINE EXPRESSION IN AIDS-RELATED NON-HODGKIN'S LYMPHOMA 120
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 120
AGGIORNAMENTI DI PATOGENESI MOLECOLARE DEI LINFOMI HIV-CORRELATI 119
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma 118
Targeting lysine-specific demethylase 1 (KDM1A/LSD1) impairs colorectal cancer tumorigenesis by affecting cancer cells stemness, motility, and differentiation 116
Clues to the pathogenesis of Waldenström Macroglobulinemia and IgM-MGUS provided by the analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors 116
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome 116
Characterization of Circulating Vesicles of Complicated and Uncomplicated Systemic Sclerosis Patients and Their Role in Vascular Dysfunction 115
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocol 115
MOLECULAR PATHOPHYSIOLOGY OF INDOLENT LYMPHOMA 115
Second-Generation Antipsychotics Induce Metabolic Disruption in Adipose Tissue-Derived Mesenchymal Stem Cells Through an aPKC-Dependent Pathway 114
Extracellular vesicles from human plasma for biomarkers discovery: Impact of anticoagulants and isolation techniques 114
Simian Virus 40 (SV40) infection in lymphoproliferative disorders: A reappraisal based on five hundred cases 114
Persistence of neutralizing antibodies to SARS-CoV-2 in first wave infected individuals at ten months post-infection: The UnIRSA cohort study 107
HUMAN HERPESVIRUS TYPE-8 (HHV-8) IN HAEMATOPOIETIC NEOPLASIA 106
A case of nodular sclerosis Hodgkin's lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman's disease: successful response to rituximab and radiotherapy 106
AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogen 105
ANALYSIS OF ABERRANT SOMATIC HYPERMUTATION (SHM) IN NON-HODGKIN LYMPHOMAS OF PATIENTS WITH HCV INFECTION 105
Genomic aberrations affecting the outcome of immunodeficiency-related diffuse large B-cell lymphoma 104
Aberrant somatic hypermutation in tumor cells of nodular lymphocyte-predominant and classical Hodgkin's lymphoma 103
DISTRIBUTION AND PATTERN OF BCL-6 MUTATIONS THROUGHOUT THE SPECTRUM OF B-CELL NEOPLASIA 102
ASPETTI MOLECOLARI DEI LINFOMI ASSOCIATI A HIV 101
THE DYNAMIC DNA METHYLOMES OF DOUBLE-STRANDED DNA VIRUSES ASSOCIATED WITH HUMAN CANCER 101
Uncommon mutation of BAX in AIDS-related non Hodgkin Lymphomas 100
Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma 99
MOLECULAR ANALYSIS OF IMMUNOGLOBULIN VARIABLE GENES IN HIV-RELATED NON HODGKIN LYMPHOMA REVEALS IMPLICATIONS FOR DISEASE PATHOGENESIS AND HISTOGENESIS 99
Simultaneous diagnosis of CD3+ T-cell large granular lymphocyte leukaemia and true thymic hyperplasia 98
THE HOST GENETIC BACKGROUND OF DNA REPAIR MECHANISMS IS AN INDEPENDENT PREDICTOR OF PROGRESSION AND OVERALL SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA 98
POINT MUTATIONS OF THE BCL-6 GENE IN BURKITT's LYMPHOMA 97
EARLY-STAGE DIFFUSE LARGE B CELL LYMPHOMA OF THE HEAD AND NECK: CLINICO-BIOLOGICAL CHARACTERIZATION AND 18 YEAR FOLLOW-UP OF 488 PATIENTS (IELSG 23 STUDY) 97
EXPRESSION PROFILE OF MUM1/IRF4, BCL-6, AND CD138/SYNDECAN-1 dEFINES NOVEL HISTOGENETIC SUBSETS OF HUMAN IMMUNODEFICIENCY VIRUS-RELATED LYMPHOMAS 96
MOST IMMUNOGLOBULIN HEAVY CHAIN SWITCH MU REARRANGEMENTS IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA ARE INTERNAL DELETIONS 96
UPO Biobank: The Challenge of Integrating Biobanking into the Academic Environment to Support Translational Research 95
CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia 95
EPIGENETIC INACTIVATION OF SUPPRESSORS OF CYTOKINE SIGNALLING IN Ph-NEGATIVE CHRONIC MYELOPROLIFERATIVE DISORDERS 94
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage 94
The role of cytokines in the pathogenesis and management of AIDS-related lymphomas 94
High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia 93
Nuclear Localization of Diacylglycerol Kinase Alpha in K562 Cells Is Involved in Cell Cycle Progression 93
OCCURRENCE OF MULTIPLE MYELOMA AFTER FLUDARABINE TREATMENT OF A CHRONIC LYMPHOCYTIC LEUKEMIA: EVIDENCE OF A BICLONAL DERIVATION AND CLINICAL RESPONSE TO AUTOLOGOUS STEM CELL TRANSPLANTATION 93
Genome wide DNA-profiling of HIV-related B-cell lymphomas 92
Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma 92
REARRANGEMENTS OF BCL6, BCL2, c-MYC AND 6q DELETION IN B-DIFFUSE LARGE CELL LYMPHOMA: CLINICAL RELEVANCE IN 71 PATIENTS 91
IDENTIFICATION OF THREE DISTINCT SUBGROUPS OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA BASED UPON MUTATIONS OF BCL-6 AND IgV GENES 90
GENETIC CHARACTERIZATION OF HHV-8/KSHV POSITIVE PRIMARY EFFUSION LYMPHOMA REVEALS FREQUENT MUTATIONS OF BCL-6: IMPLICATIONS FOR DISEASE PATHOGENESIS AND HISTOGENESIS 90
THE MOLECULAR BASIS OF AIDS-RELATED LYMPHOMAGENESIS 90
MOLECULAR PATHWAYS IN LOW GRADE B-CELL LYMPHOMA 90
Prognostic assessment of BCL2-938C>A polymorphism in chronic lymphocytic leukemia 90
Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients 90
THE MOLECULAR AND PHENOTYPIC PROFILE OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA IDENTIFIES DISTINCT CATEGORIES OF THE DISEASE AND IS CONSISTENT WITH HISTOGENETIC DERIVATION FROM GERMINAL CENTER-RELATED B-CELLS 90
MUTATION OF BAX OCCURS INFREQUENTLY IN AIDS-RELATED NON-HODGKIN'S LYMPHOMAS 90
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features 89
Molecular history of Richter syndrome: Origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis 89
Post-transplant lymphoproliferative disorders: role of viral infection, genetic lesions and antigen stimulation in the pathogenesis of the disease 89
CARATTERIZZAZIONE VIROLOGICA E MOLECOLARE DELLE PATOLOGIE LINFOPROLIFERATIVE POST-TRAPIANTO 88
IMMUNODEFICIENCY, INHERITED AND ACQUIRED, AND LYMPHOMAGENESIS 88
SUBCUTANEOUS “LIPOMA-LIKE” B-CELL LYMPHOMA ASSOCIATED WITH HCV INFECTION: A NEW PRESENTATION OF PRIMARY EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA OF MALT 88
Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion 88
Molecular histogenesis of plasmablastic lymphoma of the oral cavity 88
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes 88
HHV-8/KSHV IS NOT ASSOCIATED WITH AIDS-RELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA 87
Downregulation of the major histocompatibility complex class I molecules by human herpesvirus type 8 and impaired natural killer cell activity in primary effusion lymphoma development 87
Hairy cell leukaemia complicated by anti-MAG paraproteinemic demyelinating neuropathy: resolution of neurological syndrome after cladribrine treatment 87
COMPREHENSIVE CHARACTERIZATION OF IGHV3-21-EXPRESSING B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: AN ITALIAN MULTICENTER STUDY 86
CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH HIGHLY STABLE AND INDOLENT DISEASE SHOW DISTINCTIVE PHENOTYPIC AND GENOTYPIC FEATURES 85
INDOLENT LYMPHOMA: FROM MOLECULAR PATHOGENESIS TO MOLECULAR DIAGNOSIS 85
Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas 85
DETECTION OF BCL-6 REARRANGEMENTS AND p53 MUTATIONS IN MALT-LYMPHOMAS 84
EXPRESSION STATUS OF BCL-6 AND SYNDECAN-1 IDENTIFIES DISTINCT HISTOGENETIC SUBSETS OF HODGKIN'S DISEASE 84
DIFFERENTIAL EXPRESSION OF BCL-6, CD138/SYNDECAN-1 AND EBV-ENCODED LATENT MEMBRANE PROTEIN-1 IDENTIFIES DISTINCT HISTOGENETIC PATHWAYS OF AIDS-RELATED NON-HODGKIN's LYMPHOMAS 83
Totale 11.221
Categoria #
all - tutte 78.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.203


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.159 0 4 210 148 85 18 114 26 75 22 231 226
2022/20232.254 183 93 112 87 130 194 57 96 1.196 8 65 33
2023/2024823 43 33 61 19 124 48 229 49 3 10 67 137
2024/20251.607 21 20 23 45 51 222 124 103 437 166 52 343
2025/20265.746 208 191 467 844 393 394 827 990 472 511 339 110
2026/2027572 241 331 0 0 0 0 0 0 0 0 0 0
Totale 15.723